Financial statements Lordpharm
Balance sheet data of LORDPHARM
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 3 457 978,47 | 3 297 650,92 | 3 204 248,28 | 1 524 741,06 | 1 450 380,09 | 1 594 886,08 |
| A. Fixed assets | 852 379,32 | 1 145 845,08 | 1 116 868,44 | 471 998,39 | 531 611,43 | 435 130,12 |
| B. Current assets | 2 605 599,15 | 2 151 805,84 | 2 087 379,84 | 1 052 742,67 | 918 768,66 | 1 159 755,96 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 3 457 978,47 | 3 297 650,92 | 3 204 248,28 | 1 524 741,06 | 1 450 380,09 | 1 594 886,08 |
| A. Equity | 3 118 000,91 | 3 036 961,99 | 392 201,50 | 562 256,75 | 577 108,85 | 750 617,86 |
| B. Liabilities and provisions for liabilities | 339 977,56 | 260 688,93 | 2 812 046,78 | 962 484,31 | 873 271,24 | 843 688,22 |
| I. Long-term liabilities | 133 288,62 | 66 621,90 | 0,00 | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 202 511,60 | 192 103,02 | 2 810 191,97 | 960 680,90 | 871 408,98 | 842 113,58 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.